Publication | Open Access
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
35
Citations
17
References
2021
Year
In patients with PPFE, nintedanib treatment might be associated with slower decline in lung function, paving the way for prospective, controlled studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1